Target intelligence / Profile preview

SMAD family member 4 mRNA 3'-untranslated region (SMAD4 mRNA 3'-UTR)

Target
SMAD4 mRNA 3'-UTR
Molecular classification
RNA, Regulatory element, Untranslated region
01

Overview

The SMAD family member 4 (SMAD4) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the SMAD4 transcript that governs the post-transcriptional expression of the SMAD4 protein. As a central mediator of the transforming growth factor-beta (TGF-beta) signaling pathway, SMAD4 facilitates the translocation of SMAD complexes into the nucleus to regulate gene transcription involved in cell proliferation, differentiation, and apoptosis (UniProt P61371). The 3'-UTR contains multiple binding sites for microRNAs (miRNAs), such as miR-146a, miR-199a, and miR-224, which typically downregulate SMAD4 expression by inducing mRNA degradation or inhibiting translation (PubMed: 28656245, PubMed: 25670455). Dysregulation of this region or the miRNAs targeting it is frequently observed in various cancers, including pancreatic and colorectal carcinomas, where loss of SMAD4 function promotes epithelial-mesenchymal transition (EMT) and metastasis (PubMed: 22348011). In therapeutic contexts, the SMAD4 mRNA 3'-UTR is explored as a target for miRNA mimics or antisense oligonucleotides designed to restore or modulate SMAD4 levels in diseases like cancer and tissue fibrosis. However, targeting this region presents challenges due to the dual role of TGF-beta signaling as both a tumor suppressor and a promoter of progression, necessitating precise temporal and spatial control of SMAD4 expression.

Other names
Mothers against decapentaplegic homolog 4 mRNA 3'-UTRDPC4 mRNA 3'-UTRSMAD4 3'-UTRDeleted in pancreatic carcinoma locus 4 mRNA 3'-UTR
02

Mechanism of action

MicroRNA-mediated gene silencing and translational repression

03

Biological functions

Post-transcriptional regulationmRNA stability controlTGF-beta signaling modulationSignal transduction
04

Disease associations

Pancreatic cancerColorectal cancerMyocardial infarctionFibrosisJuvenile polyposis syndrome
05

Safety considerations

Off-target effects of RNA-based therapiesDual role of TGF-beta signaling in cancer (tumor suppressor vs. promoter)Delivery challenges for RNA therapeutics
06

Interacting drugs

miR-146a mimics (experimental)

3 more in the full profile.

07

Biomarkers

SMAD4 protein expression levelsmiR-146a expression levelsmiR-224 expression levels

Beyond the preview

Go deeper on SMAD family member 4 mRNA 3'-untranslated region (SMAD4 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMAD family member 4 mRNA 3'-untranslated region (SMAD4 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call